Business

Robotic Rehabilitation and Assistive Technologies Market: Global Segments, Scope, Trends Analysis and 2026 Industry Growth

Rehabilitation robotics and assistive technologies allow for use of robotic devices for rehabilitation of patients suffering from mobility issues. Robotic rehabilitation and assistive technologies allow for application of robotics in therapeutic procedures to help with recovery a person from various diseases or disabilities such orthopedic traumas, neuromotor disorders, cognitive diseases, strokes and spinal cord injury. Assistive robotics allows people suffering from degenerative motor and/or cognitive abilities to lead an independent life.

Get Exclusive Sample Copy @  https://www.coherentmarketinsights.com/insight/request-sample/924

According to World Health Organization (WHO) 2016, around 1 billion people worldwide suffered from some form of disability, of which around 190 million were unable to carry out daily function independently. Rapid increase in the disabilities due to increasing prevalence of disease such as rheumatoid arthritis, cerebral palsy, spinal cord injury, and other ageing disabilities are expected to increase demand for robotic rehabilitation and assistive technologies. According to WHO 2017, around 47 million people suffered from dementia, with around 10 million new cases reported each year.

This creates a highly conducive environment for growth of the robotic rehabilitation and assistive technologies market in the near future. Lack of awareness about new technologies among the populace, especially in emerging economies, and high cost of robotic rehabilitation and assistive technologies is a major factor restraining market growth.

Get Discount @ https://www.coherentmarketinsights.com/insight/request-discount/924

Key players in robotic rehabilitation and assistive technologies market include Mazor Robotics Ltd., Intuitive Surgical Inc., Accuray, Inc., Health Robotics S.R.L., Kinova, AlterG inc., Ekso Bionics, and Interactive Motion Technologies, Bioxtreme Robotics Rehabilitation, Instead Technologies. In 2016, Ekso Bionics Holdings, Inc., received U.S. Food and Drug Administration (FDA) approval for Ekso GT robotic exoskeleton. This product is used to treat an individual with hemiplegia which occur due to stroke.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.